Coronavirus (COVID-19) Vaccine Information for Providers
- About mRNA Vaccines
- Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
- Frequently Asked Questions (FAQs)
- Decision Making Information for Pregnant Woman
- Maternal Immunization Task Force Urge Vaccine Availability for Pregnant Woman
- Guidance and Resources for MediCal Program
- Notice Regarding COVID-19 Vaccine Administration
- Product Information
- Post Vaccination
- Patient Questions
- Adverse Event Reporting
- PrepMod/Training
- Scientific Workgroup Final Statement
January 21, 2021
California State Epidemiologist Dr. Erica Pan issued the following statement today advising providers that they can immediately resume the administration of lot 41L20A of the Moderna COVID-19 vaccine, which was temporarily paused on Sunday due to possible allergic reactions.
You can find the full news release at the link below: